These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1147840)

  • 21. Development of platelet contractile force as a research and clinical measure of platelet function.
    Carr ME
    Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the blood platelet phagocytic capacity depend on the sex and plasma thrombopoietic activity?
    Kemona H; Mantur M; Prokopowicz J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):690-5. PubMed ID: 2435635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on platelet-associated tissue factor and its significance].
    Huang XL; Chen FP; Du JW; Peng MY; Fu B; Xie QZ; He SL
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):525-8. PubMed ID: 16468328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect on thromboelastogram of normal blood and procoagulant activity of gel filtered uraemic platelets.
    Umiastowski J; Suchecki T
    Thromb Haemost; 1980 Feb; 42(5):1620-5. PubMed ID: 7368162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red cell stroma, a stable standard for assessment of platelet procoagulant release.
    Rhoades P; Margolis J; Lovric VA
    Pathology; 1979 Apr; 11(2):161-7. PubMed ID: 460941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose.
    Krízová P; Másová L; Suttnar J; Salaj P; Dyr JE; Homola J; Pecka M
    J Biomed Mater Res A; 2007 Aug; 82(2):274-80. PubMed ID: 17274026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation and its patient-specific consequences.
    Smyth SS; Monroe DM; Wysokinski WE; McBane RD; Whiteheart SW; Becker RC; Steinhubl SR
    Thromb Res; 2008; 122(4):435-41. PubMed ID: 17949794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
    Kempton CL; Hoffman M; Roberts HR; Monroe DM
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
    Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coagulation activity of platelets].
    Reininger AJ
    Hamostaseologie; 2007 Sep; 27(4):247-50. PubMed ID: 17938762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-sensitive mitochondrial membrane potential in human platelets and intrinsic signals of cell death.
    Leaver HA; Schou AC; Rizzo MT; Prowse CV
    Platelets; 2006 Sep; 17(6):368-77. PubMed ID: 16973497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A standardized bioassay for platelet factor 3 released by kaolin.
    Pérez-Requejo JL
    Br J Haematol; 1976 May; 33(1):39-51. PubMed ID: 1268089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shear-induced activation of platelets.
    Ramstack JM; Zuckerman L; Mockros LF
    J Biomech; 1979; 12(2):113-25. PubMed ID: 422576
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of inhibitor of glucose utilization on the blood platelet function.
    Tison P; Kubisz P; Cernácek P; Dzúrik R
    Nephron; 1983; 33(4):253-6. PubMed ID: 6843756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of platelet factor-3 activation after incubation of platelet-rich plasma with kaolin in the rat.
    Clerck FD; Goossens J; Beerens M
    Experientia; 1976 Dec; 32(12):1602-3. PubMed ID: 1021463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the availability of platelet factor 3 by increased concentration of lecithin in platelets caused by gonadal steroids.
    Lillienberg L; Korsan-Bengtsen K; Olausson M; Svanborg A
    Thromb Res; 1981 Jun 1-25; 22(5-6):579-91. PubMed ID: 7302906
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in blood coagulating and thrombocytic factors in leukemia].
    Stepanian MA; Eliian LN; Osipova EN; Pogosian AS; Muradian LB
    Zh Eksp Klin Med; 1978; 18(3):86-90. PubMed ID: 278416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.